Company / Net Income
IRADIMED CORP Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$22.5M
FY2025
5-year range
$9.3M / $22.5M
FY2021-FY2025
Trend
+16.9%
vs FY2024
Sector context
#88 of 164
Health Care
What the data says
At $22M, IRADIMED CORP's net income ranks #88 of 164 in the Health Care sector. Net Income has increased for 3 consecutive years, from $9M in FY2022 to $22M in FY2025.
Based on SEC 10-K filings.
$22M in FY2025 with a 5-year CAGR of +75.0%.
Improved from $17M to $22M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- +34.1%
- 5-Year CAGR
- +75.0%
- 10-Year CAGR
- -
Sector benchmark
#88 of 164 in Health CareTop 54% of 164This company $22.5M Sector average $467.5M
▼
-95.2% below sector average
Key checks
Key Insights
- IRADIMED CORP's net income has grown for 3 consecutive years.
- 5-year CAGR of +75.0%, indicating consistent growth.
- In FY2025, net income increased 16.9% year-over-year.
- Ranks #88 out of 164 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 5.29 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $22.5M | +16.9% |
| FY2024 | $19.2M | +11.9% |
| FY2023 | $17.2M | +84.4% |
| FY2022 | $9.3M | -3.2% |
| FY2021 | $9.6M | +603.5% |
| FY2020 | $1.4M | -85.8% |
| FY2019 | $9.6M | +33.5% |
| FY2018 | $7.2M | -4.2% |
| FY2017 | $7.5M | +267.2% |
| FY2016 | $2.1M | +0.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026